These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36057233)

  • 1. Mental health conditions and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Putaala J; Mustonen P; Kinnunen J; Jolkkonen S; Niemi M; Hartikainen J; Airaksinen KEJ; Lehto M
    Gen Hosp Psychiatry; 2022; 78():117-122. PubMed ID: 36057233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental health conditions and risk of first-ever ischaemic stroke and death in patients with incident atrial fibrillation: A nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Kouki E; Penttilä T; Hartikainen J; Aro AL; Airaksinen KEJ; Lehto M
    Eur J Clin Invest; 2022 Sep; 52(9):e13801. PubMed ID: 35484936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
    J Am Heart Assoc; 2022 Mar; 11(6):e024119. PubMed ID: 35229612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
    Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study.
    Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
    Gen Hosp Psychiatry; 2022; 74():88-93. PubMed ID: 34999528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Luojus A; Itäinen-Strömberg S; Penttilä T; Niemi M; Hartikainen J; Airaksinen KJ; Lehto M
    BMJ Open; 2022 Aug; 12(8):e059759. PubMed ID: 36041755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study.
    Søgaard M; Skjøth F; Kjældgaard JN; Larsen TB; Hjortshøj SP; Riahi S
    BMJ Open; 2017 Dec; 7(12):e018209. PubMed ID: 29217725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in treatment and outcomes of atrial fibrillation during 2007-17 in Finland.
    Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Aro AL; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2023 Nov; 9(7):673-679. PubMed ID: 36542420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of anticoagulation therapy in patients with mental health conditions.
    Paradise HT; Berlowitz DR; Ozonoff A; Miller DR; Hylek EM; Ash AS; Jasuja GK; Zhao S; Reisman JI; Rose AJ
    J Gen Intern Med; 2014 Jun; 29(6):855-61. PubMed ID: 24549520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Putaala J; Mustonen P; Kinnunen J; Jolkkonen S; Niemi M; Hartikainen J; Airaksinen KEJ; Lehto M
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101131. PubMed ID: 36246774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.
    Fenger-Grøn M; Vestergaard CH; Ribe AR; Johnsen SP; Frost L; Sandbæk A; Davydow DS
    JAMA Netw Open; 2021 May; 4(5):e2110096. PubMed ID: 33999163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
    Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
    Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of patients with atrial fibrillation and major bleeding complications: from the TREAT-AF study.
    Perino AC; Kaiser DW; Lee RJ; Fan J; Askari M; Schmitt SK; Turakhia MP
    J Interv Card Electrophysiol; 2021 Oct; 62(1):133-142. PubMed ID: 32986177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in atrial fibrillation: impact of mental illness.
    Schmitt SK; Turakhia MP; Phibbs CS; Moos RH; Berlowitz D; Heidenreich P; Chiu VY; Go AS; Friedman SA; Than CT; Frayne SM
    Am J Manag Care; 2015 Nov; 21(11):e609-17. PubMed ID: 26735294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.